First Time Use of SD-809 in Huntington Disease (First-HD)

This study has been completed.
Information provided by (Responsible Party):
Auspex Pharmaceuticals, Inc. Identifier:
First received: February 20, 2013
Last updated: June 24, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 24, 2015